Related Experiment Video
Updated: May 6, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
SNP selection in genome-wide association studies via penalized support vector machine with MAX test
Jinseog Kim1, Insuk Sohn, Dennis Dong Hwan Kim
1Department of Statistics and Information Science, Dongguk University, Gyeongju 780-714, Republic of Korea.
This study introduces a two-stage method for genome-wide association studies (GWAS) to improve prediction models. By first identifying genetic models of single-nucleotide polymorphisms (SNPs) and then using penalized support vector machines (SVMs), prediction power is enhanced.
Area of Science:
- Genetics
- Bioinformatics
- Machine Learning
Background:
- Genome-wide association studies (GWAS) aim to predict clinical outcomes using single-nucleotide polymorphisms (SNPs).
- Penalized support vector machine (SVM) methods are commonly used for prediction in GWAS.
- Ignoring SNP genetic models in current methods leads to reduced prediction efficiency.
Purpose of the Study:
- To propose a novel two-stage method for GWAS prediction models that incorporates SNP genetic models.
- To enhance the prediction power and selectivity of clinical outcome prediction using GWAS data.
Main Methods:
- A two-stage approach is proposed: first, identify SNP genetic models using the MAX test.
- Second, fit a prediction model using a penalized SVM with the identified genetic models.
- The method was applied to various penalized SVMs and compared with existing approaches.
Main Results:
- The proposed two-stage method demonstrated superior performance compared to methods that ignore genetic models.
- Enhanced prediction power and selectivity were observed in both simulations and real GWAS data analysis.
- The study compared the performance of different penalized SVMs and penalty functions.
Conclusions:
- The proposed two-stage method effectively improves prediction models in GWAS by incorporating SNP genetic models.
- This approach offers a more efficient and selective way to predict clinical outcomes using genetic data.
- The findings suggest a significant advancement in leveraging GWAS data for diagnostic and prognostic applications.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...